The CMV RT‑PCR test (real‑time polymerase chain reaction) detects and quantifies cytomegalovirus genetic material in blood, urine, CSF or other samples. It identifies active infection, measures viral load to guide treatment or monitor response, and helps assess risk in pregnancy and in immunocompromised or transplant patients. It is rapid, sensitive, and used to confirm infection or track antiviral therapy effectiveness.

A CMV PCR positive result means cytomegalovirus DNA was detected in the tested sample, indicating current or recent infection or viral reactivation. It shows active viral replication rather than past exposure. Clinical significance depends on patient context—pregnancy, newborns, or immunocompromised people may need urgent follow-up, viral load monitoring, antibody testing, and possible antiviral treatment. Consult your clinician for interpretation and management.

If CMV PCR is positive, treatment depends on symptoms and immune status. Asymptomatic immunocompetent people usually need monitoring only. Symptomatic or immunocompromised patients get antivirals—first-line ganciclovir IV or oral valganciclovir; use foscarnet or cidofovir for resistance or intolerance. Reduce immunosuppression if feasible, and monitor viral load, CBC and renal function; treat congenital or severe disease promptly.

A cytomegalovirus (CMV) test detects infection with CMV. Blood tests can identify viral DNA (PCR) or antigens indicating active infection, while antibody tests measure IgM (recent/acute) and IgG (past exposure or immunity). Testing is used to diagnose symptomatic infection, evaluate pregnant women for congenital risk, and monitor immunocompromised patients. Results guide treatment and infection-control decisions.

If CMV tests are positive, interpretation and action depend on which markers are detected. IgM suggests recent infection; IgG alone indicates past exposure. Pregnant women need urgent follow-up (repeat serology, IgG avidity, fetal monitoring and possible amniotic PCR). Immunocompromised or symptomatic patients may require antiviral therapy and specialist care. Most healthy people have mild or no symptoms—consult your clinician for personalized testing and management.

A positive RT‑PCR test means viral genetic material was detected in your sample, indicating an active or very recent infection. It suggests you may be infectious, so follow isolation and public‑health guidance. Results must be interpreted with clinical signs, exposure history and timing—RT‑PCR can sometimes detect nonviable viral fragments after recovery. Your clinician may recommend repeat testing or further evaluation as needed.